TIBER CREEK GROUP for GILEAD SCIENCES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to HIV; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIKOLE BURROUGHS | — |
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
| COREY MALMGREN | — |
| JENNIFER OLSON | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Budget/Appropriations BUD
Issues related to HIV prevention and procurement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIKOLE BURROUGHS | — |
| MATTHEW LEFFINGWELL | — |
| COREY MALMGREN | — |
| JENNIFER OLSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.